PPLPHARMA IN EQUITY
loading…—
Day range—
52-week range—
Market cap—
P/E · TTM—
As of—
| ₹ CR · FY | FY22 | FY23 | FY24 | FY25 | FY26 | Sep'26 | YOY |
|---|---|---|---|---|---|---|---|
| Profit & loss | |||||||
| Revenue | 6,559 | 7,082 | 8,171 | 9,151 | 8,869 | — | — |
| Operating profit | 950 | 629 | 1,197 | 1,445 | 922 | — | — |
| OPM % | 14.5% | 8.9% | 14.6% | 15.8% | 10.4% | — | |
| Interest | 198 | 344 | 448 | 422 | 341 | — | — |
| Profit before tax | 485 | -120 | 179 | 415 | -176 | — | — |
| Net profit | 376 | -186 | 18 | 91 | -326 | — | — |
| NPM % | 5.7% | -2.6% | 0.2% | 1.0% | -3.7% | — | |
| Balance sheet & cash | |||||||
| Total assets | 12,605 | 14,303 | 15,083 | 15,429 | 17,607 | 18,537 | +5.3% |
| Equity | 6,697 | 6,773 | 7,911 | 8,125 | 8,162 | 8,142 | −0.2% |
| Debt | 4,128 | 5,637 | 4,710 | 4,856 | 5,675 | 5,873 | +3.5% |
| Cash from ops | 766 | 484 | 1,005 | 892 | 1,653 | — | — |
| Capex | — | — | — | — | — | — | — |
| CHECK | RESULT | VALUE |
|---|---|---|
| Net profit positive | n/a | — |
| Operating cash flow positive | n/a | — |
| ROA improved | n/a | -1.9% → — |
| Cash from ops > net profit | n/a | — |
| Leverage fell | ✓ PASS | 0.32 → 0.32 |
| Current ratio improved | n/a | — → — |
| Gross margin improved | n/a | 10.4% → — |
| Asset turnover improved | n/a | 0.5 → — |
| Interest cover above 3× | n/a | — |
| ₹ CR · QUARTER | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | YOY |
|---|---|---|---|---|---|---|---|---|---|
| Profit & loss | |||||||||
| Revenue | 2,204 | 2,754 | 1,934 | 2,044 | 2,140 | 2,752 | 2,270 | 2,617 | +28.1% |
| Operating profit | 338 | 561 | 107 | 159 | 196 | 461 | 195 | 349 | +119.8% |
| OPM % | 15.3% | 20.4% | 5.5% | 7.8% | 9.1% | 16.7% | 8.6% | 13.3% | |
| Interest | 103 | 104 | 86 | 82 | 89 | 83 | 88 | 88 | +6.3% |
| Profit before tax | 67 | 273 | -79 | -46 | -94 | 43 | -7 | 82 | +276.8% |
| Net profit | 4 | 154 | -82 | -99 | -136 | -9 | -69 | 5 | +105.1% |
| NPM % | 0.2% | 5.6% | -4.2% | -4.9% | -6.4% | -0.3% | -3.1% | 0.2% |